Neogen (NEOG) Gross Profit Margin starting from the fourth quarter 2026 to fourth quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Neogen Corporation  (NASDAQ: NEOG)


Neogen's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEOG Gross Profit Margin (May 31 2026)
Q4 		(Feb 28 2026)
Q3 		(Nov 30 2025)
Q2 		(Aug 31 2025)
Q1 		(May 31 2025)
Q4
Y / Y Revenue Change -0.58 %
Seq. Revenue Change 6.89 %
Revenue In Millions $225.54
Gross Profit Margin 47.91 %
Gross Profit Margin Total Ranking # 1821
Gross Profit In Millions $108.06
Y / Y Gross Profit Change 16.38 %
Seq. Gross Profit Change 9.15 %


Commenting fourth quarter 2026 Gross Profit Margin
Neogen Corporation Gross Profit grew by 9.15 % in Q4 sequentially to 108 millions, while Revenue increased by 6.89 %, this led to improvement in the company's Gross Profit Margin to 47.91 %, Gross Profit Margin remained below Neogen Corporation average.


Observing fourth quarter 2026 results within In Vitro & In Vivo Diagnostic Substances industry 4 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1821, from total ranking in the previous quarter at 1930.
Learn about Gross Margin
NEOG's Gross Profit Margin fourth quarter 2026 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 5
Healthcare Sector # 327
Overall # 1806

Gross Profit Margin Statistics
High Average Low
53.82 % 48.14 % 40.93 %
(Nov 30 2012)   (May 31 2025)


NEOG Gross Income Trends • More of NEOG's Profitabilty Ratios • NEOG Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
NEOG's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NEOG's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NEOG's Competitors
Gross Profit Margin Profit Margin for Neogen's Suppliers
Gross Profit Margin Profit Margin for NEOG's Customers

You may also want to know
NEOG's Annual Growth Rates NEOG's Profitability Ratios NEOG's Asset Turnover Ratio NEOG's Dividend Growth
NEOG's Roe NEOG's Valuation Ratios NEOG's Financial Strength Ratios NEOG's Gross Profit Growth
NEOG's Roa NEOG's Inventory Turnover Ratio NEOG's Growth Rates NEOG's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending May 31 2026, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginMay 31 2026 MRQ Gross ProfitMay 31 2026 MRQ Revenue
Myriad Genetics Inc   66.60 %$ 127.000  Millions$ 190.700  Millions
Insight Molecular Diagnostics Inc   65.69 %$ 0.157  Millions$ 0.239  Millions
Idexx Laboratories Inc  64.04 %$ 779.087  Millions$ 1,216.585  Millions
Lantheus Holdings Inc   62.30 %$ 241.855  Millions$ 388.180  Millions
Neogen Corporation  47.91 %$ 108.062  Millions$ 225.536  Millions
Quidelortho Corp  43.26 %$ 272.900  Millions$ 630.900  Millions
Alpha Teknova Inc   40.09 %$ 4.885  Millions$ 12.185  Millions
Immucell Corporation  33.92 %$ 2.437  Millions$ 7.186  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.